Amy Fisher Sex Tape Coming This November
October 31, 2007
There’s an Amy Fisher sex tape that’s already in the can and set to be sold starting next month.
“Amy Fisher Caught on Tape” was filmed by her husband, Lou Bellera, who then sold the tape while the couple was split up. Bellera was upset at the time because the “Long Island Lolita” had started dating Joey Buttafuoco, of all people.
“I did it out of the heat of anger and passion,” Bellera explained to The New York Post.
“We were estranged. She was seeing Joey. I was seething about the whole thing. It just came to a point where I was hurt and embarrassed by it . . . and it pressed the wrong button. I just used that as a vehicle to strike back at her.”
He sold the tape to Light District Video, but in the meantime, the couple have reconciled and she is willing to forgive him and work things out.
“We have two beautiful children, and we have a nice life, so we have to think about that,” she said.
Naturally, she thought the tape was going to be for their eyes only.
“It’s all fun and games,”said Fisher. “I never thought that . . . anything like this would ever happen.”
Wyeth Recalls Several Robitussin Products From US Shelves
October 31, 2007
Wyeth Consumer Healthcare, a division of Wyeth, today announced it has initiated a voluntary recall and replacement program for all U.S. retail outlets that sell several Robitussin(R) products and Children’s Dimetapp
Cold & Chest Congestion.
The program involves removal of existing products
with a dosage cup that does not have a half-teaspoon mark, which is the
recommended dose for children age two to under six. This action is specific
to the dosage cup and not related to the medication itself. For children
age two to under six, the Company is advising consumers not to use these
medicines until the replacement products with the new cup are available.
The replacement products with the new dosage cup are expected to be
available beginning in early November 2007. Packaging for the replacement
products will be marked to indicate that the new dosage cup is included.
The recall and replacement program for these products does not affect
other Robitussin and Dimetapp cough and cold products.
Products Being Recalled & Replaced:
— Robitussin(R) Cough DM
— Robitussin(R) Cough & Cold CF
— Robitussin(R) Cough & Congestion
— Robitussin(R) Chest Congestion
— Robitussin(R) Head & Chest Congestion PE
— Robitussin(R) Cough Sugar Free DM
— Children’s Dimetapp(R) Cold & Chest Congestion
Important Instructions for Parents and Caregivers
We recommend that parents and caregivers of children age two to under
six do the following:
— Do not use these medicines in children age two to under six because
the dosage cup does not have a half-teaspoon mark, which is the dose
on the label of these products for this age group.
— Consult their healthcare professional concerning the most
appropriate
way to treat cough and cold symptoms for children age two to under
six.
— Call 1-800-762-4675 for more information.
More information on these Robitussin products or Children’s Dimetapp
Cold & Chest Congestion can be found at Dimetapp.com or Robitussin.com or
by calling 800-762-4675.
Source: Wyeth
Study Shows No Connection Between Vitamin D And Reduced Overall Cancer Deaths
October 31, 2007
No relationship was found between vitamin D levels and the overall risk of dying from cancer, according to a study published online October 30 in the Journal of the National Cancer Institute. However, higher vitamin D levels were associated with a decreased risk of colorectal cancer death.
Several epidemiological studies have supported the hypothesis that that vitamin D can reduce cancer mortality by decreasing cancer incidence or improving survival. Animal and cell studies suggest that vitamin D may reduce tumor growth and induce cancer cell death. Diet and exposure to sunlight are the major sources of vitamin D.
D. Michal Freedman, Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues analyzed data from the third national Health and Nutrition Examination Survey to examine the relationship between levels of circulating vitamin D in the blood and cancer mortality in a group of 16,818 participants aged 17 and older.
After about a decade of follow-up, 536 participants had died of cancer. Cancer mortality was not related to the level of circulating vitamin D for the overall group, nor was it related when the researchers looked at the data by sex, race, or age. But higher levels of vitamin D (80 nmol/L or more) were associated with a 72 percent reduced risk of colorectal cancer mortality, compared with lower levels (less than 50 nmol/L).
“To our knowledge, this study is the first to examine the relationship between measured serum vitamin D levels and cancer mortality for selected site and for all sites combined,” the authors write.
In an accompanying editorial, Cindy Davis, Ph.D., and Johanna Dwyer, D.Sc. of the National Institutes of Health in Bethesda, Md., discuss the complicated relationship between nutrients, like vitamin D, and cancer. They suggest that not enough is known about the benefits and limitations of vitamin D to use it for the prevention of disease or death.
“These findings must be put into the context of total diet and lifestyle. There are many risk factors other than diet for colorectal cancer, and there are many possible dietary risk factors other than vitamin D that have been linked to cancer risk,” the editorialists write.
Source: Journal of the National Cancer Institute